Liver disease is the third leading cause of death in Cystic Fibrosis (CF). Unfortunately, conventional liver function tests cannot sensitively detect it.1-3 Liver stiffness measurements via MRI and ultrasound have shown promise but are unfortunately impacted by other factors (e.g., hepatic fat) potentially resulting in over-estimation of fibrosis.4,5 We recently validated a T1-MRI assessment of biliary dilatation and fibrosis in a rat model of congenital hepatic fibrosis (Figs. 1-3).6 In this clinical study, we show that T1-MRI can be used to sensitively detect increased percent bile duct volumes in CF patients in comparison to control subjects with normal liver function.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords